BIOCON Fact Sheet, BIOCON Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON Fact Sheet    (BICN)


Alert: Discover the Makings of Potential 'Crorepati' Stocks from Richa Agarwal


Here is the latest financial fact sheet of BIOCON . For more details, see the BIOCON quarterly results and BIOCON share price and chart. For a sector overview, read our pharmaceuticals sector report.

BIOCON Price History

Price Rs 339.5
Mkt Cap Rs m 407,544
Vol '000 146.3
P/E X 41.6
P/CF X 24.8
EPS (TTM) Rs 8.2
1 Day % 5.1
No. of shares m 1,200.60
1 Week % 1.6
1 Month % -1.0
1 Year % -11.8
52 week H/L Rs 420.3/314.9
As on May 20, 2022 03:31:00 PM
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

BIOCON Financials

No. of Mths
Year Ending
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
12
Mar-20
*
12
Mar-21
*
5-Yr Chart
Click to enlarge
BIOCON  EQUITY SHARE DATA
High Rs1,1621,188718636488 
Low Rs482305544211275 
Sales per share (Unadj.) Rs193.068.691.952.559.2 
Earnings per share (Unadj.) Rs33.67.216.77.57.7 
Diluted earnings per shareRs5.63.68.37.57.7 
Cash flow per share (Unadj.) Rs47.513.624.212.113.7 
Dividends per share (Unadj.) Rs3.001.001.0000 
Adj. dividends per shareRs0.500.500.500.000.00 
Avg Dividend yield %0.40.10.200 
Book value per share (Unadj.) Rs238.585.2100.355.062.3 
Adj. book value per shareRs39.742.650.154.962.2 
Shares outstanding (eoy) m200.00600.00600.001,200.001,200.00 
Bonus / Rights / Conversions  00000 
Price / Sales ratio x4.310.96.98.16.4 
Avg P/E ratio x24.5103.737.856.549.4 
P/CF ratio (eoy) x17.354.826.135.027.9 
Price / Book Value ratio x3.48.86.37.76.1 
Dividend payout %8.913.96.000 
Avg Mkt Cap Rs m164,430447,900378,645508,380457,350 
No. of employees `000NANANANANA 
Total wages/salary Rs m7,4709,31111,65314,58817,410 
Avg. sales/employee Rs Th00000 
Avg. wages/employee Rs Th00000 
Avg. net profit/employee Rs Th00000 
BIOCON  INCOME DATA
Net Sales Rs m38,60641,17155,14463,00571,058 
Other income Rs m1,5712,0624,1435,0756,052 
Total revenues Rs m40,17743,23359,28768,08077,110 
Gross profit Rs m9,7958,29113,18413,24513,145 
Depreciation Rs m2,7723,8514,4785,5227,151 
Interest Rs m260615709649577 
Profit before tax Rs m8,3345,88712,14012,14911,469 
Minority Interest Rs m00000 
Prior Period Items Rs m00000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,6161,5692,1233,1512,215 
Profit after tax Rs m6,7184,31810,0178,9989,254 
Gross profit margin %25.420.123.921.018.5 
Effective tax rate %19.426.717.525.919.3 
Net profit margin %17.410.518.214.313.0 
BIOCON  BALANCE SHEET DATA
Current assets Rs m40,47741,48648,88553,25076,004 
Current liabilities Rs m16,78321,41330,38540,08042,101 
Net working cap to sales %61.448.833.520.947.7 
Current ratio x2.41.91.61.31.8 
Inventory Days Days1651119583137 
Debtors Days Days8494867163 
Net fixed assets Rs m51,49056,47769,79287,508106,142 
Share capital Rs m1,0003,0003,0006,0006,000 
"Free" reserves Rs m46,70248,12357,20859,97068,728 
Net worth Rs m47,70251,12360,20865,97074,728 
Long term debt Rs m21,08217,89815,25612,22229,616 
Total assets Rs m91,96797,963118,677140,758182,146 
Interest coverage x33.110.618.119.720.9 
Debt to equity ratio x0.40.40.30.20.4 
Sales to assets ratio x0.40.40.50.40.4 
Return on assets %7.65.09.06.95.4 
Return on equity %14.18.416.613.612.4 
Return on capital %12.59.417.016.411.5 
Exports to sales %00000 
Imports to sales %20.517.818.913.47.2 
Exports (fob) Rs m00000 
Imports (cif) Rs m7,8997,34810,3998,4745,084 
Fx inflow Rs m12,98812,05815,50611,75311,791 
Fx outflow Rs m7,8997,34810,3998,4745,084 
Net fx Rs m5,0894,7105,1073,2796,707 
BIOCON  CASH FLOW
From Operations Rs m 6,400 6,621 11,546 12,831 11,597 
From Investments Rs m -4,985 -6,840 -7,138 -15,589 -36,247 
From Financial Activity Rs m -1,775 -2,397 -2,417 3,876 25,640 
Net Cashflow Rs m -473 -2,612 2,103 1,654 723 
* Results Consolidated
Source: Accord Fintech, Equitymaster

Share Holding

Promoters 60.6%
Institution 24.0%
Non-Institution 15.4%
Total 100.0%
Free Float 39.4%
Pledged promoter holdings 0.0%
Shareholding as on Mar 2022
 

Company Information

Regd Off 20th Km, Hosur Road, Electronic City, Bengaluru - 560100
E-mail corporate.communications@biocon.com Web www.biocon.com
Tel 080 2808 2808 Fax 080 2852 3423
Sector PHARMACEUTICALS Group Private sector
Tr Agent K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.), Karvy Selenium Tower B Plot 31-32, Gachibowli Financial District, Nanakramguda
Auditor S. R. Batliboi & Assoc.
CHM: Kiran Mazumdar-Shaw COMP SEC: Mayank Verma YEAR OF INC: 1978 BSE CODE: 532523 FV (Rs): 5 DIV YIELD (%): -

More Pharmaceuticals Company Fact Sheets:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    

Compare BIOCON With:   SUN PHARMA    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    LUPIN    




Today's Market

4 Reasons Why Sensex Rallied 1,534 Points Today(0)

Bulls marked a strong comeback today as Indian share markets ended nearly 3% higher. After opening the day higher, equity markets extended gains as the session progressed and ended near the day's high.

Views on news

Dr Reddy's Net Profit Falls 76%. Company Declares 600% Dividend (Views On News)

May 19, 2022

During Q4, there were many changes to the products forming part of Dr Reddy's generics and proprietary products segments.

Cipla vs Sun Pharma: Which Pharma Stock is Better? (Views On News)

Apr 13, 2022

The pandemic has opened up new opportunities for the Indian pharmaceutical sector. Which company is set to benefit from it?

Nifty Pharma Index - Bulls are Losing the Ground (Views On News)

Mar 16, 2022

For the Nifty pharma index, it seems as if bulls are losing ground as they witness multiple bearish candlestick patterns.

IPO Alert! 3 Companies Including PharmEasy Get the Green Light (Views On News)

Feb 22, 2022

The strong momentum in India's IPO market is poised to continue with the market regulator approving the IPOs of three firms including PharmEasy.

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

More Views on News

Most Popular

2022's Best Performing Penny Stocks So Far... (Views On News)

Mar 2, 2022

We are just two months into 2022 and several penny stocks that we track have already surged 5x.

5 Debt Free Penny Stocks with Good Profitability to Watch Out for in 2022 (Views On News)

Mar 16, 2022

Debt free penny stocks are vital when it's a question of portfolio diversification in a volatile market. They can potentially offer good profitability in the long run.

Penny Stocks to Buy and Hold Beyond 2022 (Views On News)

Apr 6, 2022

A step-by-step method to pick the best penny stocks for the long term.

6 Penny Stocks that Could Be Hidden Bluechips. Take a Look... (Views On News)

Apr 13, 2022

These penny stocks can become future multibaggers. Watch out for them.

Adani Power vs Tata Power: Which Power Stock is Better? (Views On News)

Feb 28, 2022

Rising electricity consumption provides a lot of scope for growth. Which company has a better chance at capturing it?

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TRACK BIOCON

MORE ON BIOCON

BIOCON - TEVA PHARMA COMPARISON

COMPARE BIOCON WITH

MARKET STATS